LEGN Company Profile and Key Details
Legend Biotech Corporation
LEGN Stock Price Chart
Stock Price Today
Legend Biotech Corporation (LEGN) stock surged +7.33%, trading at $37.21 on NASDAQ, up from the previous close of $34.67. The stock opened at $37.30, fluctuating between $35.81 and $37.69 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multiple myeloma (MM), as well as a comparison of the treatment with standard triplet therapy in revlimid-refractory multiple myeloma. The company also has a portfolio of earlier-stage autologous product candidates, which are in Phase I clinical trials for the treatment of gastric cancer and T cell lymphoma. In addition, it is developing CAR-T product candidates targeting CD20/CD22/CD19 for the treatment of non-hodgkins lymphoma, diffuse large B-cell lymphoma, and acute lymphoblastic leukemia. Further, the company has product candidates in early preclinical and clinical development for the treatment of solid tumors as well as infectious diseases. It has collaboration and license agreement with Janssen Biotech, Inc. for the development and commercialization of ciltacabtagene autoleucel. Legend Biotech Corporation was founded in 2014 and is based in Somerset, New Jersey. Legend Biotech Corporation is a subsidiary of Genscript Biotech Corporation.
Company Information
| Employees | 2400 |
| Beta | 0.11 |
| Sales or Revenue | $285.14M |
| 5Y Sales Change% | 2.296% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Biotechnology |
Frequently Asked Questions
Legend Biotech Corporation (NASDAQ: LEGN) stock price is $37.21 in the last trading session. During the trading session, LEGN stock reached the peak price of $37.69 while $35.81 was the lowest point it dropped to. The percentage change in LEGN stock occurred in the recent session was 7.33% while the dollar amount for the price change in LEGN stock was $2.54.
The NASDAQ listed LEGN is part of Biotechnology industry that operates in the broader Healthcare sector. Legend Biotech Corporation designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Ms. Liz Gosen
Senior Vice President of Technical Operations
Dr. Ying Huang Ph.D.
Chief Executive Officer & Director
Mr. Alan Kick
Senior Vice President of Global Quality
Ms. Lori A. Macomber C.P.A.
Chief Financial Officer
Dr. Yuhong Qiu Ph.D.
Senior Vice President of Global Regulatory Affairs
Dr. Guowei Fang Ph.D.
Senior Vice President & Global Head of Research and Early Devel.
Mr. Marc Harrison
Vice President & Gen. Counsel
Ms. Lori A. Macomber CPA
Chief Financial Officer
Mr. Steven J. Gavel
Senior Vice President of Commercial Devel., US & Europe
Joanne Choi
Senior Mang. of Investor Relations
Ms. Elaine Qian
Vice President & Global Head of HR
Deborah Wong
Executive Director of Strategic Marketing & Corporation Communications
LEGN's closing price is 14.91% higher than its 52-week low of $30.17 where as its distance from 52-week high of $70.13 is -50.56%.
Number of LEGN employees currently stands at 2,400.
Official Website of LEGN is: https://www.legendbiotech.com
LEGN could be contacted at phone 732 317 5050 and can also be accessed through its website. LEGN operates from 2101 Cottontail Lane, Somerset, NJ 08873, United States.
LEGN stock volume for the day was 1.59M shares. The average number of LEGN shares traded daily for last 3 months was 1.47M.
The market value of LEGN currently stands at $6.83B with its latest stock price at $37.21 and 183.45M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com